← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

RVTY logoRevvity, Inc.(RVTY)Earnings, Financials & Key Ratios

RVTY•NYSE
$99.09
$11.08B mkt cap·47.6× P/E·Price updated May 6, 2026
SectorHealthcareIndustryDiagnostics & ResearchSub-IndustryLife Science Instruments and Sequencing Tools
AboutRevvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.Show more
  • Revenue$2.86B+3.7%
  • EBITDA$659M-21.4%
  • Net Income$242M-18.3%
  • EPS (Diluted)2.08-13.7%
  • Gross Margin53.08%+10.6%
  • EBITDA Margin23.07%-24.2%
  • Operating Margin12.49%-16.2%
  • Net Margin8.46%-21.2%
  • ROE3.24%-14.9%
  • ROIC2.72%-7.9%
  • Debt/Equity0.48+11.8%
  • Interest Coverage3.91-8.7%
Analysis→Technical→

RVTY Key Insights

Revvity, Inc. (RVTY) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓FCF machine: 17.8% free cash flow margin
  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Share count reduced 7.8% through buybacks
  • ✓Healthy 5Y average net margin of 11.3%

✗Weaknesses

  • ✗Weak 3Y average ROE of 1.8%
  • ✗Profits declining 19.8% over 5 years
  • ✗Sales declining 5.5% over 5 years
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

RVTY Price & Volume

Revvity, Inc. (RVTY) stock price & volume — 10-year historical chart

Loading chart...

RVTY Growth Metrics

Revvity, Inc. (RVTY) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years3.1%
5 Years-5.47%
3 Years-4.82%
TTM4.78%

Profit CAGR

10 Years1.3%
5 Years-19.79%
3 Years-24.84%
TTM-22.36%

EPS CAGR

10 Years1.04%
5 Years-20.37%
3 Years-22.69%
TTM-16.97%

Return on Capital

10 Years7.58%
5 Years5.82%
3 Years3.28%
Last Year3.16%

RVTY Recent Earnings

Revvity, Inc. (RVTY) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
May 5, 2026
EPS
$1.06
Est $1.02
+3.9%
Revenue
$711M
Est $704M
+1.0%
Q1 2026
Feb 2, 2026
EPS
$1.70
Est $1.57
+8.3%
Revenue
$772M
Est $765M
+0.9%
Q4 2025
Oct 27, 2025
EPS
$1.18
Est $1.14
+3.5%
Revenue
$699M
Est $699M
-0.1%
Q3 2025
Jul 28, 2025
EPS
$1.18
Est $1.14
+3.5%
Revenue
$720M
Est $700M
+2.9%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 5, 2026
$1.06vs $1.02+3.9%
$711Mvs $704M+1.0%
Q1 2026Feb 2, 2026
$1.70vs $1.57+8.3%
$772Mvs $765M+0.9%
Q4 2025Oct 27, 2025
$1.18vs $1.14+3.5%
$699Mvs $699M-0.1%
Q3 2025Jul 28, 2025
$1.18vs $1.14+3.5%
$720Mvs $700M+2.9%
Based on last 12 quarters of dataView full earnings history →

RVTY Peer Comparison

Revvity, Inc. (RVTY) competitors in Life Science Instruments and Sequencing Tools — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
WAT logoWATWaters CorporationDirect Competitor22.78B349.5332.486.99%11.91%8.04%0.55
BRKR logoBRKRBruker CorporationDirect Competitor6.44B42.30-2822.08%-0.75%-1.11%0.81
MTD logoMTDMettler-Toledo International Inc.Direct Competitor27B1328.1531.503.98%21.59%
BIO logoBIOBio-Rad Laboratories, Inc.Direct Competitor6.99B259.029.290.65%6.52%2.4%0.21
HOLX logoHOLXHologic, Inc.Direct Competitor16.97B76.0130.531.74%13.18%10.37%0.52
TMO logoTMOThermo Fisher Scientific Inc.Product Competitor175.76B472.9526.663.91%15.18%13.23%0.76
DHR logoDHRDanaher CorporationProduct Competitor123.8B174.9234.712.9%14.89%7.06%0.35
A logoAAgilent Technologies, Inc.Product Competitor33.31B117.6925.756.73%18.26%18.67%0.50

Compare RVTY vs Peers

Revvity, Inc. (RVTY) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs WAT

Most directly comparable listed peer for RVTY.

Scale Benchmark

vs TMO

Larger-name benchmark to compare RVTY against a more recognizable public peer.

Peer Set

Compare Top 5

vs WAT, BRKR, MTD, BIO

RVTY Income Statement

Revvity, Inc. (RVTY) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue2.26B2.78B2.88B3.78B3.83B3.31B2.75B2.76B2.86B2.9B
Revenue Growth %6.69%23.08%3.8%31.18%1.19%-13.48%-16.95%0.16%3.67%4.78%
Cost of Goods Sold1.23B1.53B1.59B1.79B1.55B1.55B1.43B1.43B1.34B1.41B
COGS % of Revenue54.39%54.96%55.16%47.38%40.38%46.84%51.93%51.99%46.92%-
Gross Profit
1.03B▲ 0%
1.25B▲ 21.6%
1.29B▲ 3.3%
1.99B▲ 53.9%
2.28B▲ 14.6%
1.76B▼ 22.8%
1.32B▼ 24.9%
1.32B▲ 0.0%
1.52B▲ 14.6%
1.49B▲ 0%
Gross Margin %45.61%45.04%44.84%52.62%59.62%53.16%48.07%48.01%53.08%51.44%
Gross Profit Growth %5.87%21.56%3.34%53.94%14.64%-22.84%-24.91%0.04%14.62%-
Operating Expenses724.72M880.27M887.57M970.72M941.95M979.61M922.7M912.14M1.16B1.13B
OpEx % of Revenue32.11%31.69%30.78%25.66%24.61%29.58%33.55%33.11%40.6%-
Selling, General & Admin585.56M694.17M698.24M765.33M741.61M757.99M706.12M715.3M945.28M914.23M
SG&A % of Revenue25.94%24.99%24.21%20.23%19.37%22.89%25.67%25.96%33.1%-
Research & Development139.16M186.1M189.34M205.39M200.34M221.62M216.58M196.84M215.84M220.13M
R&D % of Revenue6.17%6.7%6.57%5.43%5.23%6.69%7.87%7.14%7.56%-
Other Operating Expenses00000000-1.7M-1000K
Operating Income
304.63M▲ 0%
370.97M▲ 21.8%
405.48M▲ 9.3%
1.02B▲ 151.5%
1.34B▲ 31.4%
781.12M▼ 41.7%
399.49M▼ 48.9%
410.52M▲ 2.8%
356.63M▼ 13.1%
360.29M▲ 0%
Operating Margin %13.5%13.35%14.06%26.96%35.01%23.59%14.52%14.9%12.49%12.41%
Operating Income Growth %-0.34%21.78%9.3%151.5%31.4%-41.71%-48.86%2.76%-13.13%-
EBITDA409.63M551.56M619.51M1.27B1.65B1.21B831.26M838.37M658.9M668.21M
EBITDA Margin %18.15%19.85%21.48%33.48%43.14%36.48%30.22%30.43%23.07%23.02%
EBITDA Growth %0.98%34.65%12.32%104.4%30.42%-26.84%-31.19%0.86%-21.41%-19.1%
D&A (Non-Cash Add-back)105M180.59M214.03M246.51M311.44M427M431.77M427.85M302.26M307.92M
EBIT340.66M324.66M300.77M956.08M1.31B755.79M281.79M412.4M360.46M285.12M
Net Interest Income-41.37M-65.83M-62.13M-48.7M-99.89M-100.37M-26.68M-23.09M-61.08M-48.2M
Interest Income2.57M1.14M1.5M1.01M2.24M3.59M72.13M73.19M31.1M14.72M
Interest Expense43.94M66.98M63.63M49.71M102.13M103.95M98.81M96.28M92.19M93.94M
Other Income/Expense-7.92M-113.28M-168.34M-113.43M-136.42M-129.28M-216.51M-94.39M-88.36M-94.4M
Pretax Income
296.72M▲ 0%
257.68M▼ 13.2%
237.14M▼ 8.0%
906.36M▲ 282.2%
1.2B▲ 32.8%
651.84M▼ 45.8%
182.98M▼ 71.9%
316.13M▲ 72.8%
268.28M▼ 15.1%
265.89M▲ 0%
Pretax Margin %13.15%9.28%8.22%23.96%31.44%19.68%6.65%11.47%9.39%9.16%
Income Tax139.83M20.21M9.39M178.27M314.15M139.16M3.47M33.05M25.8M24.19M
Effective Tax Rate %47.12%7.84%3.96%19.67%26.1%21.35%1.9%10.46%9.62%9.1%
Net Income
113.02M▲ 0%
238.79M▲ 111.3%
227.56M▼ 4.7%
728.1M▲ 220.0%
943.16M▲ 29.5%
569.18M▼ 39.7%
-118.38M▼ 120.8%
295.83M▲ 349.9%
241.68M▼ 18.3%
240.96M▲ 0%
Net Margin %5.01%8.6%7.89%19.25%24.64%17.19%-4.3%10.74%8.46%8.3%
Net Income Growth %-51.64%111.28%-4.7%219.96%29.54%-39.65%-120.8%349.91%-18.31%-22.36%
Net Income (Continuing)156.89M237.47M227.75M728.1M889.44M512.68M179.5M283.07M242.48M241.53M
Discontinued Operations-43.87M1.31M-195K053.72M56.5M-297.88M12.76M-975K-743K
Minority Interest0000000000
EPS (Diluted)
1.02▲ 0%
2.14▲ 110.0%
2.04▼ 4.7%
6.49▲ 218.2%
8.08▲ 24.5%
4.50▼ 44.3%
-0.95▼ 121.1%
2.41▲ 353.9%
2.08▼ 13.7%
2.15▲ 0%
EPS Growth %-51.87%110%-4.67%218.23%24.47%-44.31%-121.09%353.87%-13.69%-16.97%
EPS (Basic)1.032.162.056.538.124.51-0.952.412.08-
Diluted Shares Outstanding110.86M111.53M111.5M112.08M116.67M126.43M124.81M122.82M113.21M111.88M
Basic Shares Outstanding109.86M110.56M110.83M111.51M116.17M126.16M124.7M122.76M113.21M111.88M
Dividend Payout Ratio27.25%12.99%13.65%4.29%3.43%6.21%-11.65%13.57%-

RVTY Balance Sheet

Revvity, Inc. (RVTY) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets1.2B1.23B1.37B2.24B2.44B3.29B3B2.35B2.24B2.13B
Cash & Short-Term Investments202.13M163.11M191.88M402.04M603.32M454.36M1.6B1.16B919.87M860.32M
Cash Only202.13M163.11M191.88M402.04M603.32M454.36M913.16M1.16B919.87M860.32M
Short-Term Investments000000689.92M000
Accounts Receivable552.3M632.67M725.18M1.16B707.94M612.78M632.81M632.4M744.67M691.38M
Days Sales Outstanding89.3283.1391.79111.4667.5167.5483.9783.7895.1787.32
Inventory351.68M338.35M356.94M514.57M425.89M405.46M428.06M367.59M379.5M387.5M
Days Inventory Outstanding104.5680.8981.91104.8100.5695.41109.3893.67103.3799.4
Other Current Assets93.84M100.51M100.38M167.21M703.63M1.82B337.14M186.22M195.71M189.11M
Total Non-Current Assets4.89B4.74B5.16B5.72B12.56B10.84B10.56B10.04B9.93B9.87B
Property, Plant & Equipment298.07M318.59M485.5M575.54M649.57M671.3M664.74M649.93M644.69M628.89M
Fixed Asset Turnover7.57x8.72x5.94x6.57x5.89x4.93x4.14x4.24x4.43x4.43x
Goodwill3B2.95B3.11B3.45B6.63B6.48B6.53B6.46B6.61B6.61B
Intangible Assets1.35B1.2B1.28B1.37B3.82B3.38B3.02B2.64B2.35B2.31B
Long-Term Investments00024.66M110.94M144.62M0124.94M1.16M1.16M
Other Non-Current Assets244.3M270.02M284.17M308.38M1.35B166.44M342.97M163.45M322.32M1.27B
Total Assets
6.09B▲ 0%
5.98B▼ 1.9%
6.54B▲ 9.4%
7.96B▲ 21.7%
15B▲ 88.4%
14.13B▼ 5.8%
13.56B▼ 4.0%
12.39B▼ 8.6%
12.17B▼ 1.8%
12B▲ 0%
Asset Turnover0.37x0.46x0.44x0.48x0.26x0.23x0.20x0.22x0.23x0.24x
Asset Growth %42.43%-1.9%9.42%21.74%88.44%-5.8%-4%-8.64%-1.81%-17.6%
Total Current Liabilities950.9M771.63M762.83M1.65B1.21B1.54B1.45B653.1M1.33B1.24B
Accounts Payable222.09M220.95M235.85M327.32M324.81M272.83M204.12M167.46M185.46M169.68M
Days Payables Outstanding66.0352.8254.1266.6676.6964.252.1642.6750.5245.91
Short-Term Debt217.31M14.86M9.97M380.95M4.24M470.93M721.87M242K588.83M575.83M
Deferred Revenue (Current)159.92M155.06M164.26M396.21M138.05M135.53M135.56M140.21M00
Other Current Liabilities39.46M44.69M44.52M47.49M257.79M324.85M43.28M44.18M556.95M493.13M
Current Ratio1.26x1.60x1.80x1.36x2.01x2.13x2.07x3.60x1.68x1.68x
Quick Ratio0.89x1.16x1.33x1.04x1.66x1.87x1.77x3.03x1.40x1.40x
Cash Conversion Cycle127.85111.19119.57149.5991.3798.75141.2134.78148.02140.82
Total Non-Current Liabilities2.64B2.62B2.96B2.57B6.65B5.2B4.24B4.07B3.59B3.58B
Long-Term Debt1.79B1.88B2.06B1.61B4.98B3.92B3.18B3.15B2.78B2.77B
Capital Lease Obligations00146.4M188.4M147.4M169.97M132.75M151.5M148.11M462.88M
Deferred Tax Liabilities000774.53M1.43B1.11B0000
Other Non-Current Liabilities848.57M742.31M751.47M091.7M0930.95M770.52M659.35M2.98B
Total Liabilities3.59B3.39B3.72B4.22B7.86B6.75B5.69B4.73B4.92B4.81B
Total Debt2.01B1.89B2.26B2.22B5.16B4.6B4.07B3.33B3.52B3.35B
Net Debt1.8B1.73B2.07B1.82B4.56B4.14B3.15B2.16B2.6B2.49B
Debt / Equity0.80x0.73x0.80x0.59x0.72x0.62x0.52x0.43x0.48x0.48x
Debt / EBITDA4.90x3.43x3.64x1.75x3.12x3.80x4.89x3.97x5.34x5.01x
Net Debt / EBITDA4.40x3.14x3.33x1.44x2.76x3.43x3.79x2.58x3.94x3.94x
Interest Coverage7.75x4.85x4.73x19.23x12.79x7.27x2.85x4.28x3.91x3.04x
Total Equity
2.5B▲ 0%
2.58B▲ 3.3%
2.81B▲ 8.9%
3.74B▲ 32.8%
7.14B▲ 91.2%
7.38B▲ 3.4%
7.87B▲ 6.6%
7.67B▼ 2.6%
7.25B▼ 5.4%
7.18B▲ 0%
Equity Growth %16.23%3.27%8.85%32.76%91.17%3.38%6.64%-2.61%-5.43%-22.26%
Book Value per Share22.5823.1825.2433.3361.2158.4063.0862.4264.0464.20
Total Shareholders' Equity2.5B2.58B2.81B3.74B7.14B7.38B7.87B7.67B7.25B7.18B
Common Stock110.36M110.6M111.14M112.09M126.24M126.3M123.43M120.65M00
Retained Earnings2.38B2.6B2.81B3.51B4.42B4.95B5.61B5.85B00
Treasury Stock0000000000
Accumulated OCI-46.52M-176.48M-199.65M-31.96M-162.69M-447.5M-276.69M-396.11M00
Minority Interest0000000000

RVTY Cash Flow Statement

Revvity, Inc. (RVTY) cash flow — operating, investing & free cash flow history

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations288.45M311.04M363.47M892.18M1.41B679.81M91.27M628.3M581.78M581.78M
Operating CF Margin %12.78%11.2%12.6%23.59%36.86%20.53%3.32%22.81%20.37%-
Operating CF Growth %-17.73%7.83%16.86%145.46%58.12%-51.81%-86.57%588.38%-7.4%-18.19%
Net Income156.89M237.47M227.75M630.56M889.44M512.68M179.5M283.07M241.2M240.96M
Depreciation & Amortization105M180.59M214.03M201.65M311.44M427M431.77M427.85M405.34M412.97M
Stock-Based Compensation25.42M28.77M31.51M26.9M29.68M51.52M41.41M37.81M22.85M23.83M
Deferred Taxes29.04M-51.77M-61.78M-30.82M-53.4M-107.41M-97.48M-110.31M-61.48M-61.48M
Other Non-Cash Items9.77M46.71M116.61M215.21M100.61M58.99M-72.58M8.18M70.65M29.27M
Working Capital Changes-37.66M-130.73M-164.66M-151.32M132.99M-262.97M-391.35M-18.3M-96.78M-63.48M
Change in Receivables-36.63M-94.51M-100.63M-398.85M165.59M66.09M-9M-15.97M-101.02M-57.62M
Change in Inventory-17.92M-30.18M-9.61M-127.36M32.28M-48.63M-14.11M45.09M14.78M7.43M
Change in Payables34.33M8.9M7.35M63.23M-7.58M-43.8M-76.43M-26.02M7.34M-15.25M
Cash from Investing-1.27B-159.86M-487.57M-504.5M-4.11B-132.85M1.31B776.16M-17.35M-89.25M
Capital Expenditures-39.09M-93.25M-81.33M-63.63M-86.02M-85.63M-81.37M-86.65M-73.52M-77.31M
CapEx % of Revenue1.73%3.36%2.82%1.68%2.25%2.59%2.96%3.15%2.57%-
Acquisitions-1.53B-59.66M-399.86M-407.21M-3.98B6.99M-1.93M00-67.28M
Investments----------
Other Investing272.82M72K0-13.59M-22.96M-15.91M2.07B156.9M56.55M56.79M
Cash from Financing782.24M-179.23M150.13M-202.87M2.94B-661.8M-947.12M-1.13B-855.05M-782.75M
Debt Issued (Net)822.16M-66.04M208.87M-187.47M3.04B-559.17M-517.49M-723.07M-521K-471K
Equity Issued (Net)-3.83M-57.45M-6.31M30.73M-47.95M-66.52M-388.88M-369.58M-817.89M-666.93M
Dividends Paid-30.79M-31.01M-31.06M-31.21M-32.37M-35.34M-34.97M-34.45M-32.8M-32.21M
Share Repurchases-3.83M-57.45M-6.31M-6.94M-73.07M-80.64M-388.88M-369.58M-820.82M-753.72M
Other Financing-5.29M-24.73M-21.37M-14.92M-21M-767K-5.79M-1.13M-3.84M-83.15M
Net Change in Cash
-157.13M▲ 0%
-36.05M▲ 77.1%
25.58M▲ 170.9%
210.72M▲ 723.8%
216.72M▲ 2.8%
-148.59M▼ 168.6%
443.63M▲ 398.6%
250.08M▼ 43.6%
-244.59M▼ 197.8%
-218.82M▲ 0%
Free Cash Flow
249.36M▲ 0%
217.78M▼ 12.7%
282.14M▲ 29.5%
828.54M▲ 193.7%
1.32B▲ 59.9%
594.18M▼ 55.1%
9.9M▼ 98.3%
541.65M▲ 5369.0%
508.25M▼ 6.2%
504.75M▲ 0%
FCF Margin %11.05%7.84%9.78%21.9%34.61%17.94%0.36%19.66%17.8%17.39%
FCF Growth %-21.81%-12.66%29.55%193.67%59.89%-55.15%-98.33%5369.01%-6.17%-3.69%
FCF per Share2.251.952.537.3911.354.700.084.414.494.49
FCF Conversion (FCF/Net Income)2.55x1.30x1.60x1.23x1.50x1.19x-0.77x2.12x2.41x2.09x
Interest Paid35.78M56.45M82.69M42.14M54.12M97.93M94.01M91.09M00
Taxes Paid77.61M59.84M77.06M162.45M364.56M323.08M359.8M154.88M00

RVTY Key Ratios

Revvity, Inc. (RVTY) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)4.85%9.39%8.43%22.23%17.34%7.84%-1.55%3.81%3.24%3.28%
Return on Invested Capital (ROIC)6.39%6.45%6.62%14.66%11.65%5.05%2.66%2.95%2.72%2.72%
Gross Margin45.61%45.04%44.84%52.62%59.62%53.16%48.07%48.01%53.08%51.44%
Net Margin5.01%8.6%7.89%19.25%24.64%17.19%-4.3%10.74%8.46%8.3%
Debt / Equity0.80x0.73x0.80x0.59x0.72x0.62x0.52x0.43x0.48x0.48x
Interest Coverage7.75x4.85x4.73x19.23x12.79x7.27x2.85x4.28x3.91x3.04x
FCF Conversion2.55x1.30x1.60x1.23x1.50x1.19x-0.77x2.12x2.41x2.09x
Revenue Growth6.69%23.08%3.8%31.18%1.19%-13.48%-16.95%0.16%3.67%4.78%

RVTY SEC Filings & Documents

Revvity, Inc. (RVTY) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 5, 2026·SEC

Material company update

May 1, 2026·SEC

Material company update

Feb 2, 2026·SEC

10-K Annual Reports

2
FY 2026

Feb 24, 2026·SEC

FY 2025

Feb 25, 2025·SEC

10-Q Quarterly Reports

6
FY 2025

Nov 4, 2025·SEC

FY 2025

Aug 5, 2025·SEC

FY 2025

May 6, 2025·SEC

RVTY Frequently Asked Questions

Revvity, Inc. (RVTY) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Revvity, Inc. (RVTY) reported $2.90B in revenue for fiscal year 2025. This represents a 103% increase from $1.43B in 1996.

Revvity, Inc. (RVTY) grew revenue by 3.7% over the past year. Growth has been modest.

Yes, Revvity, Inc. (RVTY) is profitable, generating $241.0M in net income for fiscal year 2025 (8.5% net margin).

Dividend & Returns

Yes, Revvity, Inc. (RVTY) pays a dividend with a yield of 0.29%. This makes it attractive for income-focused investors.

Revvity, Inc. (RVTY) has a return on equity (ROE) of 3.2%. This is below average, suggesting room for improvement.

Revvity, Inc. (RVTY) generated $504.7M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More RVTY

Revvity, Inc. (RVTY) financial analysis — history, returns, DCA and operating performance tools

Full RVTY Stock Analysis

Analyst verdict, bull/bear case, risk factors and peer comparison

→

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.